Abstract
Sudden cardiac death (SCD) affects around 300,000–450,000 people annually in the USA, representing around 50% of all cardiac deaths. Patients with a medical history of ventricular tachycardia (VT) or ventricular fibrillation (VF) run a high risk of death in the short term, and studies dating back to the 1970s have shown a 45% mortality rate at 2 years. SCD accounts for at least 50% of patient deaths from heart failure and ischemia. From 1980 onward the positive effects of automatic implantable cardiac defibrillators (ICD) in secondary prevention of SCD began to be recognized, but the suspicion that the ICD was only able to change death from sudden to expected in those patients who were too compromised to benefit from therapies other than chemotherapy caused a certain skepticism.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kuck KH, Cappato R, Siebels J, Ruppel R (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillator in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102:748
The AVID Investigators (1997) A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 337:1576–1583
Connolly SJ, Gent M, Roberts RS et al (2000) Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter against amiodarone. Circulation 101:1297–1302
Moss AJ, Hall WJ, Cannom DS et al (1997) Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med 337:1933–1940
Coumel P (1987) The management of clinical arrhythmias. An overview on invasive versus non invasive electrophysiology. Eur Heart J 8:92–99
Holmes DR Jr, Davis KB, Mock MB et al (1986) The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. Circulation 73:1254–1263
Bigger JT Jr (1997) Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery by-pass graft surgery. N Engl J Med 337:1569
Bigger JT, Whang W, Rottman JN et al (1999) Mechanism of death in the CABG Patch Trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 99:1416–1421
Berntsen RF, Gunnes P. Lie M, Rasmussen K (1993) Surgical revascularization in the treatment of ventricular tachycardia and fibrillation exposed by exercise-induced ischaemia. Eur Heart J 14:1297
Lessmeier TJ, Lehmann MH, Steinman RT et al (1994) Implantable cardioverter-defi-brillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillation. Am Heart J 128:211–218
Geelen P, Primo J, Wellens F, Brugada P (1999) Coronary artery by-pass grafting and defibrillator implantation in patients with ventricular tachyarrhythmias and ischemic heart disease. Pacing Clin Electrophysiol 22:1132–1139
Link MS, Cesarz CA, Griffith JL et al (1999) Evaluation of coronary revascularization to prevent tachycardia recurrences in survivors of ventricular fibrillation. Am J Cardiol 83:960–962
Josephson ME (1993) Clinical cardiac electrophysiology: techniques and interpretations, 2nd edn. Lea & Febiger, Philadelphia London
Brugada J, Aguinaga L, Mont L et al (2001) Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome. J Am Coll Cardiol 37:529–533
The Multicenter Post-Infarction Research Group (1983) Risk stratification and survival after myocardial infarction. N Engl J Med 309:331–336
Brodsky MA, Mitchell LB, Halperin BD et al (2002) AVID Investigators. Prognostic value of baseline electrophysiologic studies in patients with sustained ventricular tachyarrhythmia: the Antiarrhythmic versus Implantable Defibrillators (AVID) Trial. Am Heart J 144:478
Morady F, DiCarlo L, Winston S et al (1984) Clinical features and prognosis of patients with out of hospital cardiac arrest and a normal electrophysiologic study. J Am Coll Cardiol 4:39–44
Manolis AS, Rastegar H, Estes M (1993) Effects of coronary artery by pass grafting on ventricular arrhythmias: results with electrophysiological testing and long-term follow up. Pacing Clin Electrophysiol 16:984–991
Natale A, Sra J, Axtell K et al (1994) Ventricular fibrillation and polymorphic ventricular tachycardia with critical coronary artery stenosis: does by-pass surgery suffice? J Cardiovasc Electrophysiol 5:988–994
Kelly P, Ruskin JN, Vlahakes GJ et al (1990) Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol 15:267–273
Wiesfeld AC, Crijns HJ, Hillege HL et al (1995) The clinical significance of coronary anatomy in post-infarct patients with late sustained ventricular tachycardia or ventricular fibrillation. Eur Heart J 16:818–824
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Italia
About this paper
Cite this paper
Lunati, M. et al. (2004). Mechanical/Surgical Revascularization in Patients with Ventricular Fibrillation and Coronary Artery Disease: Is It Enough, or Do We Also Need an Implantable Cardioverter Defibrillator?. In: Raviele, A. (eds) Cardiac Arrhythmias 2003. Springer, Milano. https://doi.org/10.1007/978-88-470-2137-2_53
Download citation
DOI: https://doi.org/10.1007/978-88-470-2137-2_53
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2177-8
Online ISBN: 978-88-470-2137-2
eBook Packages: Springer Book Archive